Meeting category
Date(s)
9 Sep 2015 - 10 Sep 2015
Program Language
English
Location
Frankfurt, Germany
Meeting type
Live Meeting
Organizer
Founding Father
Sponsor logos
Gilead - Creating Possible

European Roundtable on Hepatitis Cure & Eradication 2015

Related Enduring Materials

Enduring Materials

Day 1 - Wednesday, 9 September 2015

-
Where are we now?
Stefan Zeuzem, MD
J.W. Goethe University Hospital, Germany
Global Plans - The Toronto Declaration
Charles Boucher, MD, PhD
Erasmus Medical Center, The Netherlands
Session 1: Epidemiology HCV/HBV in Europe -
Current Epidemiology data on HCV/HBV in Europe
Homie Razavi, PhD
Center for Disease Analysis (CDA), Louisville CO, United States
Progression of the disease
Heiner Wedemeyer
Heiner Wedemeyer, MD
Medical School Hannover, Germany
Mortality projection in the coming years
Maria Buti, MD, PhD
Hospital General Universitari Valle Hebron, Spain
Session 2: Underdiagnosing - How to solve it -
New screening / testing technologies
Stéphane Chevaliez, PharmD, PhD
University of Paris-Est Creteil, France
Screening policies
Angelos Hatzakis, MD, PhD, MSc
Athens University Medical School, Greece
Session 3: Modelling the possibilities of cure and eradication What are the gaps and challenges? -
Hepatitis C Treatment as Prevention: What is needed for elimination among key risk groups (PWID and MSM) in Europe?
Natasha Martin
Natasha Martin, DPhil
University of California San Diego, USA
Epidemiology, influence on the MSM population
Maria Prins
Maria Prins, MD
GGD Amsterdam, Netherlands

Day 2 - Thursday, 10 September 2015

Session 4: Developing National Plans in Europe -
Spain
Rafael Esteban, MD
Hospital Vall’ Hebron, Spain
Scotland
John Dillon
John Dillon, MD
University of Dundee, Scotland
France
Daniel Dhumeaux
Daniel Dhumeaux, MD
Ministry of Health, France
Germany
Heiner Wedemeyer, MD
Heiner Wedemeyer, MD
Medical School Hannover, Germany
Georgia
Tengiz Tsertvadze, MD, PhD
Tengiz Tsertsvadze MD, PhD
AIDS and Clinical Immunology Research Center, Tblisi, Georgia
Poland
Robert Flisiak
Robert Flisiak, MD, PhD
Medical University of Bialystok, Poland
Session 5: Roundtable Discussion -
Panel members
Ricardo Baptista Leite
Ricardo Baptista Leite, MD, PhD, MP
Member of Parliament, Portugal
John Dillon
John Dillon, MD
University of Dundee, Scotland
Jackie Redding,
Jackie Redding, MD, Bsc (hons) Msc
Terrence Higgins Trust, United Kingdom
Charles Gore
Charles Gore, MD
World Hepatitis Allience, United Kingdom
placeholder3
Margaret Walker
European Liver Patients Association, Belgium
Overview

A highly successful European Roundtable on Hepatitis Cure and Eradication was held on 9 and 10 September, in Frankfurt, Germany.

The Program Committee would like to thank all speakers and participants for their contribution.

We thank our sponsors Gilead and AbbVie for making this event possible.

The endorsement of the different European Hepatitis Societies and the participation of the European Organizations have emphasized the importance and impact of this new meeting.

Committees
Organizing Committee

The members of the Organizing Committee (OC) discuss, on a frequent basis, the scientific program of the workshop, identify interesting topics and candidate speakers.

Support
Founding Father
Support
Endorsers